Schizoaffective disorder is a chronic mental health condition characterized by symptoms of both schizophrenia and mood ...

Discover the truth behind 11 common bipolar disorder myths. Learn the facts to better understand this complex condition and ...

Autobahn Therapeutics, a biotechnology company developing restorative treatments for people affected by neuropsychiatric and neuroimmunologic disorders, today announced the clearance of an ...

Mood stabilizers for bipolar disorder are safe during pregnancy and may even protect against preterm delivery and low birth weight.

For women with bipolar, menopause can bring extra challenges. Here’s what to know and how to manage both during this life ...

AbbVie has entered a collaboration with Hungary-based pharmaceutical company Gedeon Richter to develop new treatments for ...

Reading memoirs and nonfiction about bipolar disorder helps connect with those living with this brain-based condition, ...

What It’s Like Living With a Spouse Who Is Bipolar Verywell Health's content is for informational and educational purposes only. Our website is not intended to be a substitute for professional medical ...

These newer agents appear to be effective in the treatment of bipolar disorder, especially for those patients with rapid cycling, dysphoric or mixed mania, or neurologic abnormalities.

Researchers found that a 10-week course of home-based transcranial direct current stimulation (tDCS) significantly improved ...

It is a valuable resource for research to better understand bipolar disorder and make treatments easier to get and more likely to work. The biobank has been active for over a decade and keeps growing.

AbbVie will buy Aliada Therapeutics for $1.4 billion in cash, it said on Monday, gaining access to the privately held therapy developer's Alzheimer's disease candidate as the U.S. drugmaker increases ...